Literature DB >> 9155997

The role of mebendazole in the surgical treatment of central nervous system hydatid disease.

P Erdinçler1, M Y Kaynar, O Babuna, B Canbaz.   

Abstract

Although hydatid disease is the most common human disease caused by helminths, cerebral and spinal involvement in hydatid disease is rare. Recurrence is common when cysts rupture during surgical removal. The authors present the results of combined treatment with surgery and mebendazole in four cerebral and five spinal cases of hydatid disease. The patients' ages ranged between 4 and 55 years with a mean of 26 years. In three of the four cranial patients who received mebendazole treatment, the cysts ruptured during surgical removal. Four of the five spinal cases had recurrent disease at the time of admission. Mebendazole was started immediately after surgery and continued over 12 months. All cases but one are stable clinically or radiologically at a mean 27 months follow-up period.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155997     DOI: 10.1080/02688699746456

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

Review 1.  Toward precision medicine in glioblastoma: the promise and the challenges.

Authors:  Michael D Prados; Sara A Byron; Nhan L Tran; Joanna J Phillips; Annette M Molinaro; Keith L Ligon; Patrick Y Wen; John G Kuhn; Ingo K Mellinghoff; John F de Groot; Howard Colman; Timothy F Cloughesy; Susan M Chang; Timothy C Ryken; Waibhav D Tembe; Jeffrey A Kiefer; Michael E Berens; David W Craig; John D Carpten; Jeffrey M Trent
Journal:  Neuro Oncol       Date:  2015-05-01       Impact factor: 12.300

2.  Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.

Authors:  Ren-Yuan Bai; Verena Staedtke; Colette M Aprhys; Gary L Gallia; Gregory J Riggins
Journal:  Neuro Oncol       Date:  2011-07-15       Impact factor: 12.300

Review 3.  Spinal cystic echinococcosis--a systematic analysis and review of the literature: part 2. Treatment, follow-up and outcome.

Authors:  Andreas Neumayr; Francesca Tamarozzi; Sam Goblirsch; Johannes Blum; Enrico Brunetti
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.